BlackRock, Inc. 13D and 13G filings for Adverum Biotechnologies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-07-16 7:02 pm Sale |
2025-06-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
BlackRock Inc. BLK |
414,485 2.000% |
-1,076,224 (-72.20%) |
Filing |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
BlackRock Inc. BLK |
1,490,709 7.200% |
0 (Unchanged) |
Filing |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Adverum Biotechnologies, Inc. ADVM |
BlackRock Inc. BLK |
1,490,709 7.200% |
1,490,709 (New Position) |
Filing |